Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-20

Clinical Trial Update: Use of GM-CSF Treatment in Recurrent Implantation Failure [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating GM-CSF treatment for recurrent implantation failure in IVF is in an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GM-CSF (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy | Conditions: Women With Recurrent Implantation Failure in IVF | Phase 3 | Status: UNKNOWN